LMAT vs. ZBH

Last updated Jun 4, 2026

LMAT (LeMaitre Vascular, Inc.) and ZBH (Zimmer Biomet Holdings, Inc.) are both stocks. Both are in the Healthcare sector — LMAT in Medical Instruments & Supplies, ZBH in Medical Devices. Over the past 10 years, LMAT returned 21.12%/yr vs -2.46%/yr for ZBH. At a 0.24 correlation, their price movements are largely independent.

Performance

LMAT vs. ZBH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in LeMaitre Vascular, Inc. (LMAT) and Zimmer Biomet Holdings, Inc. (ZBH). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, LMAT achieves a 13.54% return, which is significantly higher than ZBH's -5.24% return. Over the past 10 years, LMAT has outperformed ZBH with an annualized return of 21.12%, while ZBH has yielded a comparatively lower -2.46% annualized return.

LMAT

• 1D: 0.02%
• 1M: -17.63%
• YTD: 13.54%
• 6M: 8.43%
• 1Y: 11.61%
• 3Y*: 13.29%
• 5Y*: 13.41%
• 10Y*: 21.12%

ZBH

• 1D: 1.47%
• 1M: 2.79%
• YTD: -5.24%
• 6M: -8.23%
• 1Y: -6.51%
• 3Y*: -12.39%
• 5Y*: -10.52%
• 10Y*: -2.46%

*Multi-year figures are annualized to reflect compound growth (CAGR)

LMAT vs. ZBH - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
LMAT LeMaitre Vascular, Inc.	13.54%	-10.95%	63.63%	24.60%	-7.40%	25.10%	14.09%	53.77%	-25.13%	26.58%
ZBH Zimmer Biomet Holdings, Inc.	-5.24%	-14.03%	-12.46%	-3.81%	4.24%	-17.02%	3.77%	45.37%	-13.30%	17.86%

Correlation

The correlation between LMAT and ZBH is 0.37, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.37
Correlation (3Y) Calculated over the trailing 3-year period	0.35
Correlation (5Y) Calculated over the trailing 5-year period	0.40
Correlation (10Y) Calculated over the trailing 10-year period	0.37
Correlation (All Time) Calculated using the full available price history since Oct 20, 2006	0.24

The correlation between LMAT and ZBH shifts across timeframes, from 0.24 (all time) to 0.40 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap LMAT : $2.11B ZBH : $16.64B
EPS LMAT : $2.68 ZBH : $3.85
PE Ratio LMAT : 34.25 ZBH : 22.07
PEG Ratio LMAT : 1.47 ZBH : 0.32
PS Ratio LMAT : 8.34 ZBH : 2.00
PB Ratio LMAT : 5.19 ZBH : 1.13
Total Revenue (TTM) LMAT : $256.28M ZBH : $8.41B
Gross Profit (TTM) LMAT : $185.52M ZBH : $5.89B
EBITDA (TTM) LMAT : $90.48M ZBH : $2.21B

Return for Risk

LMAT vs. ZBH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LMAT

LMAT Risk / Return Rank: 51
LMAT Sharpe Ratio Rank: 52
LMAT Sortino Ratio Rank: 51
LMAT Omega Ratio Rank: 49
LMAT Calmar Ratio Rank: 52
LMAT Martin Ratio Rank: 52

ZBH

ZBH Risk / Return Rank: 30
ZBH Sharpe Ratio Rank: 32
ZBH Sortino Ratio Rank: 28
ZBH Omega Ratio Rank: 28
ZBH Calmar Ratio Rank: 32
ZBH Martin Ratio Rank: 31

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LMAT vs. ZBH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for LeMaitre Vascular, Inc. (LMAT) and Zimmer Biomet Holdings, Inc. (ZBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	LMAT	ZBH	Difference
Sharpe ratio Return per unit of total volatility	0.32	-0.22	+0.54
Sortino ratio Return per unit of downside risk	0.89	-0.08	+0.97
Omega ratio Gain probability vs. loss probability	1.10	0.99	+0.12
Calmar ratio Return relative to maximum drawdown	0.53	-0.26	+0.79
Martin ratio Return relative to average drawdown	1.09	-0.51	+1.61
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

LMAT vs. ZBH - Sharpe Ratio Comparison

The current LMAT Sharpe Ratio is 0.32, which is higher than the ZBH Sharpe Ratio of -0.22. The chart below compares the historical Sharpe Ratios of LMAT and ZBH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	LMAT	ZBH	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.32	-0.22	+0.54
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.37	-0.40	+0.77
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.51	-0.09	+0.60
Sharpe Ratio (All Time) Calculated using the full available price history	0.34	0.18	+0.16

Drawdowns

LMAT vs. ZBH - Drawdown Comparison

The maximum LMAT drawdown since its inception was -75.69%, which is greater than ZBH's maximum drawdown of -65.03%. Use the drawdown chart below to compare losses from any high point for LMAT and ZBH.

Drawdown Indicators

	LMAT	ZBH	Difference
Max Drawdown Largest peak-to-trough decline	-75.69%	-65.03%	-10.66%
Max Drawdown (1Y) Largest decline over 1 year	-21.93%	-25.54%	+3.61%
Max Drawdown (3Y) Largest decline over 3 years	-33.32%	-43.94%	+10.62%
Max Drawdown (5Y) Largest decline over 5 years	-37.93%	-48.62%	+10.69%
Max Drawdown (10Y) Largest decline over 10 years	-47.65%	-52.14%	+4.49%
Current Drawdown Current decline from peak	-21.74%	-48.89%	+27.15%
Average Drawdown Average peak-to-trough decline	-18.95%	-20.05%	+1.10%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.65%	12.72%	-2.07%

Volatility

LMAT vs. ZBH - Volatility Comparison

LeMaitre Vascular, Inc. (LMAT) has a higher volatility of 10.03% compared to Zimmer Biomet Holdings, Inc. (ZBH) at 7.44%. This indicates that LMAT's price experiences larger fluctuations and is considered to be riskier than ZBH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LMAT	ZBH	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.03%	7.44%	+2.59%
Volatility (6M) Calculated over the trailing 6-month period	29.18%	20.09%	+9.09%
Volatility (1Y) Calculated over the trailing 1-year period	36.54%	30.38%	+6.16%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	36.40%	26.60%	+9.80%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	41.46%	28.43%	+13.03%

Dividends

LMAT vs. ZBH - Dividend Comparison

LMAT's dividend yield for the trailing twelve months is around 0.98%, less than ZBH's 1.13% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
LMAT LeMaitre Vascular, Inc.	0.98%	1.23%	0.69%	0.99%	1.09%	0.88%	0.94%	0.95%	1.18%	0.69%	0.71%	0.93%
ZBH Zimmer Biomet Holdings, Inc.	1.13%	1.07%	0.91%	0.79%	0.75%	0.76%	0.62%	0.64%	0.93%	0.80%	0.93%	0.86%

Financials

LMAT vs. ZBH - Profitability Comparison

The chart below illustrates the profitability comparison between LeMaitre Vascular, Inc. and Zimmer Biomet Holdings, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

LMAT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, LeMaitre Vascular, Inc. reported a gross profit of 48.40M and revenue of 66.55M. Therefore, the gross margin over that period was 72.7%.

ZBH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Zimmer Biomet Holdings, Inc. reported a gross profit of 1.51B and revenue of 2.09B. Therefore, the gross margin over that period was 72.4%.

LMAT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, LeMaitre Vascular, Inc. reported an operating income of 17.78M and revenue of 66.55M, resulting in an operating margin of 26.7%.

ZBH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Zimmer Biomet Holdings, Inc. reported an operating income of 373.20M and revenue of 2.09B, resulting in an operating margin of 17.9%.

LMAT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, LeMaitre Vascular, Inc. reported a net income of 15.68M and revenue of 66.55M, resulting in a net margin of 23.6%.

ZBH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Zimmer Biomet Holdings, Inc. reported a net income of 238.10M and revenue of 2.09B, resulting in a net margin of 11.4%.

Frequently Asked Questions

Can I hold both LMAT and ZBH in my portfolio?

LMAT and ZBH have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, LMAT or ZBH?

LMAT has higher volatility (10.03%) compared to ZBH (7.44%). In terms of maximum drawdown, LMAT dropped -75.69% vs ZBH's -65.03%.

Which has better risk-adjusted returns?

LMAT currently has the higher Sharpe Ratio (0.32 vs -0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.